Houston Methodist and One Medical Announce Partnership Focused on Seamless Coordinated Care

    NEXT STORY
    Selecta Biosciences and Sobi Announce Topline Data of SEL-212 from the Phase 2 COMPARE Trial Supporting the Potential for Important Clinical Improvement in Patients with Chronic Refractory Gout
    PREV STORY
    G1 Therapeutics Announces Chief Executive Officer Succession Plan
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Chembio Diagnostics Announces Collaboration with FIND to Develop Hepatitis C Virus Point-of-Care Diagnostic Test

    MEDFORD, N.Y. and GENEVA, July 28, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), ...

    author_avatar
    NASDAQ Market News

    ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update

    author_avatar
    NASDAQ Market News

    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019

    author_avatar
    NASDAQ Market News